COMMUNIQUÉS West-GlobeNewswire

AliveCor Launches KardiaACCESS: A Medicare-Covered Program Built to Improve Blood Pressure, Diabetes, and Heart Health
15/09/2026
Under the new CMS ACCESS Model, eligible Original Medicare beneficiaries can receive clinician-guided care and medical-grade connected tools to lower health risks at $0 out-of-pocket cost MOUNTAIN VIEW, Calif., Sept. 15 [...]
Le KFSH de Riyad ne relève aucun constat à haut risque sur près de 1 800 critères évalués lors du renouvellement de son accréditation JCI
15/09/2026
RIYAD, Arabie saoudite, 15 sept. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) de Riyad a obtenu le renouvellement de son accréditation en tant que centre médical universitaire [...]
Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
15/09/2026
DALLAS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ( www.InvestorsTape.com ) -- The Chief Executive Officer of NeOnc Technologies Holdings (NASDAQ:NTHI), Amir F. Heshmatpour has purchased another 37,000 shares of the company’s [...]
Ally Medical ER Collects More Than 16,000 Items for Texas Shelter Pets
15/09/2026
The freestanding emergency room's annual Pet Supply Donation Drive more than doubled last year's record. AUSTIN, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Shelter pets across Texas have fresh food, toys and comfort [...]
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
15/09/2026
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with closing expected in Q4 calendar 2026 Commercial effort concentrated on [...]
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
15/09/2026
FDA clearance of a new IND for GTB-5550 in multiple myeloma (MM) under an investigator sponsored trial (IST) protocol Initiation of Phase 1 trial in MM patients contingent upon timing and receipt of non-dilutive grant [...]
AMA and Atalan Launch Collaboration to Advance Physician Retention Research
15/09/2026
CHICAGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) and Atalan today announced a new research collaboration focused on advancing understanding of the factors that influence physician [...]
Touro University Awards Shlomo Rechnitz Honorary Doctorate for Contributions to Healthcare and Philanthropy
15/09/2026
Recognition honors Rechnitz's longstanding commitment to healthcare, charitable giving, education, and community leadership LOS ANGELES, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Touro University has awarded Shlomo Rechnitz, [...]
Nice Healthcare Supports Employers with Launch of New Health Plan
15/09/2026
New offering pairs Nice Healthcare’s in-home and virtual primary care with clinician-led care navigation, powered by a partnership with Garner Health, to help employers fight rising premiums without cutting benefits [...]
Applied Biologics Launches APPB-429 Gene Therapy Program for Diabetic Peripheral Neuropathy
15/09/2026
New program targets peripheral nerve regeneration and restoration of nerve function SCOTTSDALE, Ariz., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Applied Biologics today announced the launch of APPB-429, a new gene therapy [...]
Clene Announces $4 Million Registered Direct Offering
15/09/2026
Investment led by Clene’s Chairman of the Board of Directors, alongside founding investor Kensington Capital Holdings, Clene’s Chief Executive Officer and other existing shareholders $4 million registered direct [...]
SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit
15/09/2026
HydraScalp with Keravive study highlights improvements in scalp hydration and overall scalp quality following a single treatment Hydrafacial study shows improvements in skin hydration and overall skin quality following [...]
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
15/09/2026
Landmark independent study reports significantly improved task performance and satisfaction and lower pain compared with wheelchair use ReWalk users with chronic spinal cord injury were able to perform everyday kitchen [...]
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
15/09/2026
Company leaders, elected officials and community stakeholders will come together on September 16, 2026 to mark milestone in advanced biopharmaceutical manufacturing CANTON, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- [...]
Orvida Pharma Announces Interim Financing Led by Recordati to Advance Ontivatrep Development for Rare Genetic Skin Diseases
15/09/2026
Proceeds to support continued clinical development of ontivatrep, an oral TRPV3 inhibitor, with Phase 1b topline results in Olmsted syndrome expected by the end of 2026 NESS ZIONA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE [...]
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
15/09/2026
Statistically significant benefits observed in bezisterim-treated Long COVID patients in pre-specified subgroups with high baseline fatigue, cognitive impairment, and/or post‑exertional malaise Bezisterim showed a [...]
Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026
15/09/2026
TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”), a commercial-stage international biopharmaceutical company focused on cannabinoid-based medicines, is pleased to announce that [...]
Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence
15/09/2026
Vanguard healthcare, policy, and community stakeholders consolidate as newly formed Ontario Nicotine Action Table (ONAT) to build long-term plan for coordinated action TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- A broad [...]
Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab
15/09/2026
Strategic CDMO collaboration strengthens Axiom’s development infrastructure as the company prepares to advance its therapeutic pipeline. SAN DIEGO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences , a clinical-stage [...]

Pages